← SynDRA
AZD-5438
SynDRA canonical compound SYN0011652 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | CCNB1 | CCNE1 | CDK1 | CDK2 | KCNH2 |
| Mechanism of action | CDK inhibitor |
All known targets
- CDK2
- CDK1
- CDK9
- CCNB1
- CDK19
- CDK8
- CDK7
- CDK6
- CDK5
- CDK4
- CDK3
- CDK20
Mechanisms of action (all sources)
- CDK1 INHIBITOR
- cyclin-dependent kinase inhibitor
- CDK4/6 inhibitor
- CDK2 INHIBITOR
- CDK5 INHIBITOR
- CDK7 INHIBITOR
- CDK3 INHIBITOR
- CDK16 INHIBITOR
- CDK18 INHIBITOR
- CDK8 INHIBITOR
- CDK17 INHIBITOR
- CDK11B INHIBITOR
Cross-references
Synonyms
- AZD 5438
- AZD5438
- 4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine
- CHEMBL488436
- UNII-276Z913G29
- MMV676604
- 4-[2-METHYL-1-ISOPROPYL-1H-IMIDAZOL-5-YL]-N-[4-(METHYLSULFONYL)PHENYL]-2-PYRIMIDINAMINE
- 2-Pyrimidinamine,4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]-N-[4-(methylsulfonyl)phenyl]-
- 276Z913G29
- 4-(2-methyl-3-propan-2-ylimidazol-4-yl)-N-(4-methylsulfonylphenyl)pyrimidin-2-amine
- 4-(2-methyl-3-propan-2-yl-imidazol-4-yl)-~{N}-(4-methylsulfonylphenyl)pyrimidin-2-amine
- 4-(1-isopropyl-2-methyl-1h-imidazol-5-yl)-N-[4-(methylsulfonyl)phenyl]pyrimidin-2-amine
- FB8
- MLS006011033
- GTPL8473
- SCHEMBL5092360
- CHEBI:91419
- AMY2766
- EX-A069
- BCPP000368
- DTXSID501025680
- HMS3295K15
- HMS3656B05
- HMS3750K15
- ACT06825
- BCP02271
- AZD5438,AZD 5438
- BDBM50246253
- NSC799348
- s2621
- ZINC40442496
- AKOS005145565
- BCP9000353
- CCG-268315
- EX-8669
- NSC-799348
- SB19462
- NCGC00346617-01
Look up AZD-5438 in the interactive SynDRA portal →